Dupont Capital Management’s TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary PACE.WS Stock Holding History

Dupont Capital Management’s Portfolio PACE.WS Stock Details PACE.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,000	Closed	-$9K	–	2001
2021 Q2	$9K	Hold	5,000	–	–	﹤0.01%	1665
2021 Q1	$7K	Hold	5,000	–	–	﹤0.01%	1548
2020 Q4	$11K	Buy	+5,000	New	+$11.8K	﹤0.01%	1286

Other funds holding PACE.WS

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Dupont Capital Management's PACE.WS Position: Q3 2021 in Review

Dupont Capital Management sold out of TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary (PACE.WS) in Q3 2021, closing a stake of 5,000 shares — an estimated $9K sold.

Dupont Capital Management first reported a position in PACE.WS in Q4 2020 and held it in 3 quarters. The position peaked at $11K in Q4 2020. 1 fund tracked by Wall St. Rank holds PACE.WS as of Q3 2021.

Dupont Capital Management reported no remaining TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary position as of Q3 2021 after selling out during the quarter.
Dupont Capital Management sold 5,000 TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary shares in Q3 2021, an estimated $9K.
Dupont Capital Management first reported a position in TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary in Q4 2020 and held it in 3 quarters.
Dupont Capital Management's TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary position peaked at $11K in Q4 2020.
1 fund tracked by Wall St. Rank held TPG Pace Tech Opportunities Corp. Warrants, each whole warrant exercisable for one Class A ordinary as of Q3 2021.

Based on Dupont Capital Management's 13F filing for Q3 2021, filed 3 Nov 2021.